Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

300 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study.
Praiss AM, Miller A, Smith J, Lichtman SM, Bookman M, Aghajanian C, Sabbatini P, Backes F, Cohn DE, Argenta P, Friedlander M, Goodheart MJ, Mutch DG, Gershenson DM, Tewari KS, Wenham RM, Wahner Hendrickson AE, Lee RB, Gray H, Secord AA, Van Le L, O'Cearbhaill RE. Praiss AM, et al. Among authors: aghajanian c. Gynecol Oncol. 2023 Jul;174:213-223. doi: 10.1016/j.ygyno.2023.05.013. Epub 2023 May 23. Gynecol Oncol. 2023. PMID: 37229879 Clinical Trial.
Chemotherapy in gynecologic cancer.
Sabbatini P, Aghajanian C, Spriggs D. Sabbatini P, et al. Among authors: aghajanian c. Curr Opin Oncol. 1998 Sep;10(5):429-33. doi: 10.1097/00001622-199809000-00010. Curr Opin Oncol. 1998. PMID: 9800113 Review.
New agents for the treatment of ovarian cancer: the next generation.
Dupont J, Aghajanian C, Sabbatini P, Spriggs DR. Dupont J, et al. Among authors: aghajanian c. Int J Gynecol Cancer. 2005 Nov-Dec;15 Suppl 3:252-7. doi: 10.1111/j.1525-1438.2005.00443.x. Int J Gynecol Cancer. 2005. PMID: 16343241 Free article. Review.
300 results